Showing 1 - 5 results of 5 for search 'J. J. Cornelissen', query time: 0.04s Refine Results
  1. 1
    Variable EBV DNA Load Distributions and Heterogeneous EBV mRNA Expression Patterns in the Circulation of Solid Organ versus Stem Cell Transplant Recipients

    Variable EBV DNA Load Distributions and Heterogeneous EBV mRNA Expression Patterns in the Circulation of Solid Organ versus Stem Cell Transplant Recipients by A. E. Greijer, S. J. Stevens, S. A. Verkuijlen, H. Juwana, S. C. Fleig, E. A. Verschuuren, B. G. Hepkema, J. J. Cornelissen, R. A. Brooimans, L. F. Verdonck, J. M. Middeldorp

    Published 2012-01-01
    Get full text
    Article
  2. 2
    Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study

    Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study by A. Schauwvlieghe, A. Dunbar, E. Storme, A. Vlak, R. Aerts, J. Maertens, B. Sciot, T. Van Der Wel, G. Papageorgiou, I. Moors, J.J. Cornelissen, B.J.A. Rijnders, T. Mercier

    Published 2021-05-01
    Get full text
    Article
  3. 3
    S238: MATCHED RELATED VERSUS UNRELATED VERSUS HAPLOIDENTICAL DONORS FOR ALLOGENEIC TRANSPLANTATION IN AML PATIENTS ACHIEVING FIRST COMPLETE REMISSION AFTER TWO INDUCTION COURSES: A STUDY FROM THE ALWP/EBMT

    S238: MATCHED RELATED VERSUS UNRELATED VERSUS HAPLOIDENTICAL DONORS FOR ALLOGENEIC TRANSPLANTATION IN AML PATIENTS ACHIEVING FIRST COMPLETE REMISSION AFTER TWO INDUCTION COURSES: A... by A. Nagler, M. Labopin, S. Mielke, J. Passweg, D. Blaise, T. Gedde-Dahl, J. J. Cornelissen, U. Salmenniemi, I. Yakoub-Agha, P. Reményi, G. Socié, G. Van Gorkom, H. Labussière-Wallet, X.-J. Huang, M. Thérèse Rubio, J. L Byrne, C. Craddock, L. Griskevicius, F. Ciceri, M. Mohty

    Published 2022-06-01
    Get full text
    Article
  4. 4
    Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

    Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation f... by Eolia Brissot, Myriam Labopin, Ian Moiseev, J. J. Cornelissen, Ellen Meijer, Gwendolyn Van Gorkom, Montserrat Rovira, Fabio Ciceri, Laimonas Griskevicius, Didier Blaise, Edouard Forcade, Martin Mistrik, Stephan Mielke, Claude Eric Bulabois, Riitta Niittyvuopio, Eric Deconinck, Annalisa Ruggeri, Jaime Sanz, Alexandros Spyridonidis, Bipin Savani, Sebastian Giebel, Arnon Nagler, Mohamad Mohty

    Published 2020-07-01
    Get full text
    Article
  5. 5
    P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.

    P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION. by C. C. Kockerols, J. J. Janssen, N. M. Blijlevens, S. K. Klein, L. G. van Hussen-Daenen, G. N. van Gorkom, W. M. Smit, P. van Balen, B. J. Biemond, M. J. Cruijsen, M. F. Corsten, P. A. te Boekhorst, H. R. Koene, G. L. van Sluis, J. J. Cornelissen, P. E. Westerweel

    Published 2022-06-01
    Get full text
    Article

Search Tools: